Target intelligence / Profile preview

Synthetic Notch receptor (SynNotch)

Target
SynNotch
Molecular classification
Receptor, Synthetic/chimeric receptor, Cell-surface signaling molecule
01

Overview

Synthetic Notch receptor (synNotch) is a modular, chimeric cell-surface receptor inspired by the endogenous Notch receptor, which enables programmable sensing and response functions in mammalian cells. It is composed of an extracellular domain that binds a user-defined ligand (such as an antigen or cell-surface protein), a minimal Notch regulatory core (juxtamembrane and transmembrane regions), and an intracellular domain that is released upon ligand engagement and proteolytic cleavage to regulate expression of chosen target genes or transcription factors. This design allows for highly customizable cell behaviors, including logic-gated responses, combinatorial antigen detection (especially in engineered T cells), and spatially precise control of cellular differentiation, patterning, and therapeutic activity. SynNotch constructs have been optimized to reduce background activity and improve specificity, and they function orthogonally to endogenous signaling pathways. Safety and efficacy remain active research areas, particularly in clinical applications for cancer immunotherapy and regenerative medicine.

Other names
synNotch receptorsynthetic NotchsynNotchsynNQ
02

Mechanism of action

Drugs like γ-secretase inhibitors block proteolytic cleavage required for receptor signaling. Antibody–antigen interactions (synthetic ligands cause conformational changes and proteolytic activation, leading to intracellular domain release and transcriptional activation).

03

Biological functions

Signal transduction (contact-, ligand-dependent, proteolysis-activated transcription)Cell fate determinationCell differentiationSpatial patterningCustom gene expression in response to defined extracellular cues
04

Disease associations

Cancer (primarily in synthetic immunotherapy, e.g., engineered T cells)Other (used for tissue engineering, regenerative medicine, and studying cell-cell communication)
05

Safety considerations

Off-target activation or unintentional gene expression if input recognition is not sufficiently specificImmunogenicity of engineered domainsPotential for toxicity due to aberrant gene activationRegulatory and control challenges in therapeutic use
06

Interacting drugs

γ-secretase inhibitors (e.g., DAPT), which block synNotch cleavage and signaling

1 more in the full profile.

07

Biomarkers

None established for patient selection; biomarker design is user-specified based on engineered cell applications

Beyond the preview

Go deeper on Synthetic Notch receptor (SynNotch).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synthetic Notch receptor (SynNotch).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call